Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
ILS | Fiscal Year Ending | | Latest |
(in millions) | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | Dec-22 | Dec-23 | Dec-24 | | Dec-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 114 | 104 | 36 | 60 | 59 | 56 | 55 | 120 | 184 | 175 | | 175 |
% Growth | NA | -8.2% | -65.8% | 68.2% | -1.4% | -4.7% | -3.3% | 119.9% | 53.6% | -5.3% | | |
| | | | | | | | | | | | |
Cost of Revenue | (61) | (63) | (28) | (26) | (24) | (25) | (38) | (76) | (131) | (80) | | (80) |
Gross Profit | 52 | 41 | 8 | 34 | 35 | 32 | 17 | 44 | 53 | 95 | | 95 |
% Revenue | 45.9% | 39.2% | 22.1% | 56.4% | 59.9% | 56.3% | 30.8% | 36.3% | 28.9% | 54.2% | | 54.2% |
| | | | | | | | | | | | |
Research and Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Selling and Marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
General and Admin | (14) | (12) | (11) | (9) | (7) | (6) | (13) | (37) | (24) | (25) | | (25) |
Other Inc / (Exp) | (26) | 10 | 25 | 1 | (17) | (8) | (14) | 3 | 14 | 7 | | 7 |
Total Operating Exp | (39) | (2) | 13 | (7) | (24) | (14) | (26) | (35) | (10) | (18) | | (18) |
| | | | | | | | | | | | |
Operating Income | 13 | 39 | 21 | 27 | 11 | 18 | (10) | 9 | 43 | 77 | | 77 |
% Revenue | 11.2% | 37.0% | 59.6% | 44.5% | 19.2% | 32.0% | -17.6% | 7.3% | 23.5% | 44.1% | | 44.1% |
| | | | | | | | | | | | |
Interest Expense | (42) | (41) | (0) | (9) | (8) | (7) | (11) | (38) | (30) | (31) | | (31) |
Pre-tax Income | (29) | (2) | 21 | 18 | 3 | 11 | (21) | (29) | 13 | 46 | | 46 |
Earnings of Discontinued Ops. | 10 | 9 | 11 | 21 | 0 | 0 | 7 | 10 | 0 | 0 | | 0 |
Provision for Taxes | 1 | (11) | (2) | (2) | (4) | (2) | 2 | (3) | (8) | (39) | | (39) |
Net Income to Company | (18) | (4) | 31 | 36 | (1) | 9 | (12) | (22) | 5 | 7 | | 7 |
% Margin | -16.0% | -4.1% | 85.6% | 60.7% | -1.0% | 16.4% | -22.3% | -18.6% | 2.8% | 4.1% | | 4.1% |
| | | | | | | | | | | | |
Minority Interest in Earnings | 3 | 4 | (4) | (4) | (0) | (1) | 1 | 2 | 1 | (1) | | (1) |
Net Income to Stockholders | (15) | (0) | 27 | 33 | (1) | 8 | (12) | (21) | 6 | 6 | | 6 |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | (10) | (9) | (11) | (21) | 0 | 0 | (7) | (10) | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | (26) | (10) | 16 | 12 | (1) | 8 | (19) | (30) | 6 | 6 | | 6 |
% Margin | -22.6% | -9.2% | 45.2% | 19.7% | -1.4% | 14.3% | -34.2% | -25.4% | 3.3% | 3.7% | | 3.7% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | (0.78) | (0.29) | 0.49 | 0.36 | (0.03) | 0.24 | (0.57) | (0.91) | 0.17 | 0.17 | | 0.17 |
Diluted EPS (Continuing Ops) | (0.78) | (0.29) | 0.49 | 0.36 | (0.03) | 0.24 | (0.57) | (0.91) | 0.16 | 0.17 | | 0.17 |
| | | | | | | | | | | | |
WA Basic Shares Out. | 32.95 | 32.95 | 32.95 | 32.95 | 32.95 | 32.95 | 32.95 | 33.53 | 36.22 | 37.69 | | 37.69 |
WA Diluted Shares Out. | 32.95 | 32.95 | 32.95 | 32.95 | 32.95 | 32.95 | 32.95 | 33.53 | 37.85 | 37.69 | | 37.69 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | (29) | (2) | 21 | 18 | 3 | 11 | (21) | (29) | 13 | 46 | | 46 |
Addback: Net Interest Expense | 42 | 41 | 0 | 9 | 8 | 7 | 11 | 38 | 30 | 31 | | 31 |
Addback: Other Non Operating Expenses, Total | 26 | 17 | (5) | (1) | 15 | 8 | 14 | (3) | (14) | (4) | | (4) |
Addback: Depreciation & Amortization | 41 | 43 | 31 | 25 | 15 | 14 | 24 | 55 | 57 | 61 | | 61 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | (3) | (4) | 0 | (1) | (1) | (1) | (0) | (0) | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Assets | (3) | (26) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Asset Writedown | 3 | 5 | (20) | 0 | 3 | 1 | 0 | 0 | 0 | 0 | | 0 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Adjusted EBITDA | 78 | 74 | 28 | 50 | 44 | 40 | 28 | 61 | 87 | 134 | | 134 |
% Margin | 68.4% | 70.7% | 78.8% | 83.1% | 73.5% | 70.9% | 52.2% | 50.9% | 47.1% | 77.0% | | 77.0% |
| | | | | | | | | | | | |
Adjusted EBIT | 36 | 30 | (3) | 25 | 29 | 26 | 4 | 6 | 29 | 73 | | 73 |
% Margin | 32.1% | 29.2% | -9.3% | 42.1% | 48.2% | 45.8% | 7.7% | 4.9% | 15.9% | 42.0% | | 42.0% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | (18) | (4) | 31 | 36 | (1) | 9 | (12) | (22) | 5 | 7 | | 7 |
Addback: Unusual Items | (3) | (25) | (20) | (1) | 2 | (1) | (0) | (0) | 0 | 0 | | 0 |
Less: Tax Benefit of Unusual Items (26%) | 1 | 7 | 5 | 0 | (1) | 0 | 0 | 0 | 0 | 0 | | 0 |
Adjusted Net Income | (20) | (23) | 16 | 36 | 1 | 9 | (12) | (22) | 5 | 7 | | 7 |
% Margin | -17.7% | -22.2% | 44.3% | 59.8% | 1.5% | 15.6% | -22.6% | -18.6% | 2.8% | 4.1% | | 4.1% |